Scientist works to reduce side effects of radiation therapy
Main Category: Radiology / Nuclear MedicineArticle Date: 19 Apr 2005 - 0:00 PDT
|
|
| Patient / Public: | ![]() |
4.5 (4 votes) |
| Healthcare Prof: | ![]() |
4 (1 votes) |
| Article Opinions: | 1 posts |
A Wake Forest University Baptist Medical Center researcher has received a $1.5 million grant to study whether the same drugs that fight obesity and diabetes may be able to also prevent a common side effect of cancer treatment - the cognitive problems that can follow whole-brain radiation.
"Radiation is an effective treatment, but 20 to 40 percent of patients who get whole-brain radiation develop cognitive impairment within a year," said Mike Robbins, Ph.D., professor of radiation biology. "Their families and friends notice that they aren't as sharp as they used to be. The impairment is chronic and progressive."
These cognitive problems can include difficulty with concentration, language, memory and abstract reasoning.
With funding from the National Cancer Institute, Robbins will test whether drugs designed to block certain receptors in the brain can help prevent brain injury from radiation. About 175,000 cancer patients each year receive radiation treatments that target the whole brain or large areas of the brain.
Currently, there are no known treatments to prevent cognitive impairment that can result from the treatment. Robbins said that the aging American population makes it imperative to solve the problem.
"Cancer is a disease of old age, so the number of people getting whole-brain radiation will increase," he said.
Robbins says that, in essence, radiation speeds up the brain's aging process. Researchers believe the cause may be chronic inflammation or oxidative stress, which occurs when cells cannot remove free radicals, or structurally unstable cells that can damage healthy cells.
Robbins' project is based on new evidence that some of the same drugs used to treat obesity and diabetes may also prevent inflammation. In laboratory studies, he will explore the use of drugs that block peroxisome proliferator-activated receptors (PPARs). These receptors are known to control fat and glucose metabolism, and new evidence suggests they are also involved in inflammation.
Drugs already on the market are designed to treat obesity and diabetes by blocking the receptors. Robbins believes that the same drugs may be able to prevent or reduce the severity of cognitive impairment after whole-brain radiation.
"The drugs are available and we know the doses that patients can safely take," said Robbins. "If our theory is successful in the laboratory, this could easily be applied to patients. We know the drugs don't promote tumor growth, and in some cases may inhibit it."
This is one of several research projects looking for way to reduce the side effects of whole brain radiation. Robbins is also evaluating a blood pressure medication and a drug used to treat Alzheimer's disease as potential treatments for patients undergoing radiation. He has worked for more than 20 years on the effects of radiation in normal tissue.
Robbins' project is part of $4.5 million in research grants recently awarded to the Brain Tumor Center of Excellence. The goal of the center, which was formed in 2004, is to find better treatments - and one day a cure - for malignant brain tumors. In addition to its focus on research, the center provides a comprehensive program for patient care, and is the first center in the state to offer Gamma Knife stereotactic radiosurgery, a knifeless approach to brain surgery and radiation therapy.
Media Contacts: Karen Richardson, krchrdsn@wfubmc.edu; Shannon Koontz, shkoontz@wfubmc.edu; at 336-716-4587
About Wake Forest University Baptist Medical Center: Wake Forest Baptist is an academic health system comprised of North Carolina Baptist Hospital and Wake Forest University Health Sciences, which operates the university's School of Medicine. The system comprises 1,282 acute care, psychiatric, rehabilitation and long-term care beds and is consistently ranked as one of "America's Best Hospitals" by U.S. News & World Report.
Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4453
Wake Forest University Baptist Medical Center
http://www.wfubmc.edu
Visit our radiology / nuclear medicine section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/23017.php>
APA
http://www.medicalnewstoday.com/releases/23017.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Side Effects of Radiation Therapy
posted by Gregory Pawelski on 31 Jul 2005 at 6:48 amRadiation-induced necrosis is a serious reaction to radiation treatment. It may result from the death of tumor cells and associated reaction in surrounding normal brain or it may result from the necrosis of normal brain tissue surrounding the previously treated metastatic brain tumor. Such reactions tend to occur more frequently in larger lesions, either primary brain tumors or metastatic tumors.
Radiation-induced necrosis has been estimated to occur in 20% to 25% of patients for cancerous tumors in the brain. Some studies say it can develop in at least 40% of patients irradiated for tumor following large volume or whole brain radiation and possibly 3% to 9% of patients irradiated focally for brain tumors (in reality, they just don't know). Even with more localized use of radiation, significant neurological deficits can result.
Those at increased risk for long-term radiation effects are generally children less than 2 years of age and adults over 50 years of age. However, whole brain radiation therapy has been recognized to cause considerable permanent side effects mainly in patients over 60 years of age; it can affect up to 90% of patients in this age group.
The diagnosis of radiation-induced necrosis is difficult to confirm. Many patients have a mixture of tumor and radiation necrosis and a biopsy may be necessary to distinguish it. Neither symptoms nor radiographic findings clearly distinguish radiation-induced necrosis from tumor. However, the FDG-PET Scan and T1-SPECT studies are useful in differentiating radiation-induced necrosis from recurrent tumor.
Hyperbaric Oxygen Therapy (HBO) is now a useful therapeutic option for patients with confirmed symptomatic radiation necrosis. Until the new millenium, the only treatment for patients was pentoxifyline or heparin therapy, and it was almost always unsuccessful. The good news about HBO Therapy is, it works!
The most common condition treated at some Hyperbaric Oxygen Therapy Centers is tissue injury caused by brain radiation therapy for cancer. Wound healing requires oxygen delivery to the injured tissues. Radiation damaged tissue has lost blood supply and is oxygen deprived. Chronic radiation complications result from scarring and narrowing of the blood vessels within the area which has received the treatment. Hyperbaric Oxygen Therapy provides a better healing environment and leads to the growth of new blood vessels in a process called re-vascularization. It also fights infection by direct bacteriocidal effects. Using hyperbaric treatment protocols, numerous patients with chronic radiation injuries can be cured.
Hyperbaric oxygen therapy is administered by delivering 100 percent oxygen at pressures greater than atmospheric (sea level) pressure to a patient in an enclosed chamber. Hyperbaric oxygen acts as a drug, eliciting varying levels of response at different treatment depths, durations and dosages, and has been proven effective as adjunctive therapy for specifically indicated conditions.
Oxygen is a natural gas that is absolutely necessary for life and healing. Purified oxygen is defined as a drug but is the most natural of all drugs. Oxygen under pressure is still the same gas but is more able to penetrate into parts of the body where the arterial flow is hindered, producing ischemia (loss of blood flow) and hypoxia (lack of oxygen). When oxygen under pressure is breathed by a patient in a sealed chamber, it is termed a hyperbaric oxygen treatment (HBOT).
In addition to raising the arterial levels of oxygen 10 to 15 times higher than that produced by normal atmospheric pressure, the pressure exerted within the body can and does exert therapeutic benefits on acute and chronically traumatized and swollen tissus.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




